A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
Clinical trial NCT04488705 · COMPLETED
Trial details
- NCT number
- NCT04488705
- Sponsor
- Enterprise Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2021-05-19
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.